DICE Therapeutics Current Cash

DICE Therapeutics (DICE) currently reports a current cash of $73M as of June 2023. That compares with $17M in the prior-year period — up 338.1% year over year. Use the charts on this page to explore DICE Therapeutics's current cash history and peer comparisons.

DICE Therapeutics's current cash increased from $17M to $73M — a 338.1% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DICE Therapeutics reported $73M in current cash as of June 2023. That compares with $17M in the prior-year period — up 338.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $73M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DICE Therapeutics, and consider following DICE for alerts when major investors trade the stock.

DICE Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $73M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DICE with unrelated industries.